You are here

Pfizer quarterly revenue soars 19.7%

38204219 - 28_04_2016 - US-HEALTH-PHARMACEUTICAL-DOCTORSWITHOUTBORDER.jpg
US drugmaker Pfizer Inc reported a 19.7 per cent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.

[BENGALURU] US drugmaker Pfizer Inc reported a 19.7 per cent rise in quarterly revenue, boosted by sales of its new treatments for cancer and its Hospira acquisition.

The company's revenue rose to US$13.01 billion in the first quarter, from US$10.86 billion a year earlier.

Net income rose to US$3.02 billion, or 49 cents per share, from US$2.38 billion, or 38 cents per share.

Pfizer and Allergan Inc walked away from their US$160 billion merger in April, citing new US Treasury rules aimed at blocking the deal's tax benefits.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes